- Oct
- 2021
Asialaw 2022 Rankings
Once again, the Firm is placed in Tier 1 for IP and Pharma & Lifesciences
Remfry & Sagar has once again been recognised as ‘Outstanding’ for ‘Intellectual Property’ in the Asialaw 2022 Rankings. It is also placed in the top tier for ‘Pharmaceuticals and Life Sciences’.
In addition, Ashwin Julka (Managing Partner) has been recognised as an ‘Elite Practitioner’, Ranjna Mehta-Dutt (Partner – Patents) as a ‘Distinguished Practitioner’ and C.A. Brijesh (Partner – IP Litigation) as a ‘Notable Practitioner’.